10x Genomics Inc (TXG) Unusual Options Activity Today

Checking TXG unusual options activity helps you spot when traders are making outsized bets on 10x Genomics Inc before the broader market catches on. 10x Genomics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor TXG unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching TXG unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking TXG unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and TXG unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment.

The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Catalysts rarely arrive without a footprint, and TXG unusual options activity is often where that footprint shows up first. Our scanner tracks 10x Genomics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at TXG unusual options volume on the call side or chasing put sweeps, 10x Genomics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.